GxP Compliance
Quality Assurance
Veeva Preferred Partner

Build a Quality Program That Scales.

From establishing robust quality programs to guiding your CSV-to-CSA transition, we partner with life sciences leaders to accelerate quality outcomes - turning compliance into a competitive advantage and freeing your teams to focus on modernization.

Transition from Computer System Validation (CSV) to risk-based Computer Software Assurance (CSA) with confidence.

computer system validation 06
computer system validation 06
GxP-Compliant Programs
CSV & CSA Expertise
Internal Audit Ready
FDA / EMA / ICH Aligned
Pharma, Biotech & CRO
300+
Validations & Programs CSV/CSA engagements completed
Zero
Critical Audit Findings Across CSA transitions
40%
Reduction in CSV Documentation Effort Average post-CSA program
GAMP 5 & CSA
Risk-based validation

Quality Programs That Don't Adapt = Audit Risk

Organizations with outdated quality approaches face regulatory exposure, inefficient validation processes, and difficulty scaling with growth.

1

Outdated Quality Programs

Legacy quality approaches not aligned with current regulations (21 CFR Part 11, Annex 11, ICH Q9/Q10)

2

CSV Documentation Burden

Heavy validation paperwork without risk-based thinking - critical but excessive testing and traceability overhead

3

Unclear CSV→CSA Path

Confusion about transitioning from traditional validation to risk-based assurance - no clear methodology

4

Reactive Compliance

Issues discovered during regulatory audits instead of caught internally - missed opportunities to remediate proactively

5

Inconsistent Validation

Different validation approaches across systems and teams - no unified quality program framework

6

Quality Program Doesn't Scale

As organizations grow (startup to mid-market), quality programs break - procedures and controls become ad-hoc

Reactive vs. Proactive Quality

Most organizations manage quality reactively. Spotline transforms quality into a competitive advantage.

Traditional Approach
CSV-heavy documentation without risk assessment
One-size-fits-all validation for all systems
Compliance by external auditor findings
Quality SOP disconnected from daily operations
Annual program reviews only
VS
Spotline Proactive
Risk-based CSV/CSA approach - test effort proportional to risk
Risk-tiered validation - critical systems get rigorous testing
Proactive internal audits - find and fix before regulators
Integrated quality program - embedded in systems and teams
Continuous monitoring & improvement cycles

Our 4-Phase Methodology

A structured, repeatable approach to building and transforming quality programs from CSV to CSA.

1

Quality Program Assessment & Gap Analysis

We evaluate your current quality program against FDA, EMA, and ICH guidelines. Risk assessment of your GxP applications. Identify gaps in procedures, controls, and validation readiness. Benchmark against industry standards.

Deliverable: Gap Analysis Report + Roadmap
2

Program Design & Standards Development

Design a risk-based quality program tailored to your organization size and complexity. Develop SOPs for validation planning, execution, documentation, and change control. Define CSV-to-CSA transition strategy aligned with GAMP 5 Second Edition risk-based thinking. Create validation standards and testing frameworks.

Deliverable: Quality SOP Suite + Validation Framework
3

Implementation & Validation Execution

Execute validation plans for your critical GxP applications using the new risk-based framework. Implement quality program procedures across your organization. Train your teams on the new approach. Execute CSV/CSA validations with proportional effort. Generate audit-ready evidence.

Deliverable: Validated Systems + Audit-Ready Evidence
4

Sustainment, Auditing & Continuous Improvement

Proactive internal audits of your quality program and GxP systems. Identify findings before external auditors do. Recommend remediations and continuous improvements. Ongoing training and procedure updates. Quarterly program reviews and metrics tracking.

Deliverable: Audit Program + Remediation Plans + Program Health Metrics

Service Offerings

Three core services that transform how you build and validate quality programs.

Quality Program Establishment & Optimization

Build a robust quality program from scratch or optimize an existing one. Whether you're a startup scaling fast or a legacy pharma modernizing your approach, we establish SOPs, validation frameworks, and controls aligned with current GxP regulations. Risk-based methodology ensures you're not over-validating.

Quality-Program-Establishment

CSV to CSA Transition

Navigate the shift from Computer System Validation (documentation-heavy) to Computer Software Assurance (risk-based thinking). Understand which systems warrant deep validation and which can use lighter-touch assurance. Reduce validation documentation overhead by 30-40% while maintaining regulatory compliance. Your team learns to think risk-first.

CSV-to-CSA-Transition

GxP Validation & Internal Audits

Execute CSV/CSA validations for your critical GxP applications - ERP, LIMS, electronic batch records, document management, e-signature systems. Perform proactive internal audits to find issues before external regulators do. Generate audit-ready evidence. Remediate findings. Your organization becomes audit-confident.

GxP-Validation

Deep Quality Expertise

Our methodology is built on methodologies, standards, and years of life sciences domain experience.

Quality Program Establishment & Optimization

Quality Program Strategy & Design

Risk-aligned SOPs, validation frameworks, and quality metrics tailored to your organization's size and complexity.

csv to csa validation

CSV/CSA Validation Methodology

GAMP 5 Second Edition aligned. Risk-based testing approach reduces documentation while maintaining compliance.

Risk-Based Approach

Risk-Based Approach (CSA Alignment)

ICH Q9 quality risk management. FDA & EMA guidance aligned. Testing effort proportional to system criticality.

Audit

Internal System Audits & Remediation

Proactive audits find issues before regulators. Remediation planning and evidence generation included.

GxP Compliance Assessment & Gap Analysis

GxP Compliance Assessment & Gap Analysis

Comprehensive evaluation of your quality program against 21 CFR Part 11, EU Annex 11, and ICH guidelines.

Quality Program Sustainment & Training

Quality Program Sustainment & Training

Ongoing training, procedure updates, quarterly reviews, and continuous improvement cycles embedded in your operations.

Measurable Quality Program Impact

Organizations that embed quality programs early see immediate and sustained improvements.

300+
Validations Completed
Across all regulated industries and GxP systems
Zero
Critical Audit Findings
Average across all active quality programs
40+
Reduction in Documentation
Average across all active quality programs
100+
Audit-Ready Programs
Organizations are prepared for regulatory inspection

Trusted by Quality & Compliance Leaders

Organizations across the life sciences spectrum rely on Spotline to build scalable, audit-ready quality programs.

Spotline helped us transition from a CSV-focused approach to risk-based CSA thinking without losing regulatory confidence. Our validation cycles shortened by 30% and we found critical gaps in our quality program before an FDA audit. They became an extension of our Quality team.

30% shorter validation cycles · 0 critical audit findings

As we scaled from 50 to 200+ people, our ad-hoc quality approach broke. Spotline rebuilt our quality program from the ground up - procedures, validation framework, internal audit program. We're now audit-ready and scaling confidently.

Full program rebuild · Audit-ready in 4 months

Ready to Build a Quality Program That Scales?

Share your current quality program maturity level and GxP system landscape, and we'll demonstrate how Spotline's CSV/CSA Services can transform quality from a compliance burden into a competitive advantage.

Your initial consultation is with a senior quality architect who understands life sciences and GxP regulations.

GAMP 5 & CSA Certified
300+ Quality Programs
Zero Critical Findings
FDA / EMA / ICH Aligned
Biotech to Global Pharma